BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 6714503)

  • 1. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases.
    Christiansen JV; Holm P; Reymann F; Thestrup-Pedersen K
    Dermatologica; 1984; 168(3):122-6. PubMed ID: 6714503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Kriazheva SS; Butov IuS
    Vestn Dermatol Venerol; 1990; (5):4-6. PubMed ID: 2402940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate may work where acitretin fails.
    Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
    Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease.
    Rosén K
    Acta Derm Venereol Suppl (Stockh); 1988; 137():1-52. PubMed ID: 3285630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H; Esca SA; Holubar K
    Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E; Hidalgo H
    Med Cutan Ibero Lat Am; 1983; 11(5):369-71. PubMed ID: 6230492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemic etretinate treatment on natural cytotoxicity, immune angiogenesis and neutrophil adherence in patients with various forms of psoriasis.
    Majewski S; Wolska H; Jabłońska S; Wasik M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):459-64. PubMed ID: 2484150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etretinate therapy for generalized pustular psoriasis in children.
    Shelnitz LS; Esterly NB; Honig PJ
    Arch Dermatol; 1987 Feb; 123(2):230-3. PubMed ID: 3545086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.
    Moy RL; Kingston TP; Lowe NJ
    Arch Dermatol; 1985 Oct; 121(10):1297-301. PubMed ID: 3862363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulval lichen sclerosus et atrophicus treated with etretinate (Tigason).
    Mørk NJ; Jensen P; Hoel PS
    Acta Derm Venereol; 1986; 66(4):363-5. PubMed ID: 2430416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy.
    Seppälä J; Laulainen M; Reunala T
    Clin Rheumatol; 1988 Dec; 7(4):498-503. PubMed ID: 3149925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.